Destructive Interactions Between Murine Macrophages, Tumor Cells, and Antibodies of the IgG2a Isotype

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

1982 • 285 citations

Progress in immunology V

1985 • 268 citations

Role of oxygen-dependent mechanisms in antibody-induced lysis of tumor cells by activated macrophages

1980 • 192 citations

Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis.

1984 • 123 citations

Role of activated macrophages in antibody-dependent lysis of tumor cells.

1980 • 103 citations

Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.

1983 • 96 citations

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.

1983 • 59 citations

Studies on the antibody-dependent cell-mediated cytotoxicity (ADCC) of thioglycollate-stimulated and BCG-activated peritoneal macrophages

1981 • 37 citations

Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.

1981 • 27 citations

Immunologic control of the ascites form of murine adenocarcinoma 755. IV. Characterization of the protective antibody in hyperimmune serum.

1981 • 27 citations

Suppression of Antibody-Sensitized Tumor Cells by Macrophages: Insufficient Supply or Activation of Macrophages within Large Tumors

1979 • 23 citations

Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: Quantification of target binding and subsequent target lysis

1984 • 21 citations